UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13D
(AMENDMENT NO. 3)
Under the Securities Exchange Act of 1934
DIXON TICONDEROGA COMPANY
--------------------------------------------------------------------------------
(Name of Issuer)
Common Stock, $1.00 par value
--------------------------------------------------------------------------------
(Title of Class of Securities)
255860108
--------------------------------------------------------------------------------
(CUSIP Number)
Jarden Corporation
555 Theodore Fremd Avenue
Rye, New York 10580
Attention: Martin E. Franklin
(914) 967-9400
--------------------------------------------------------------------------------
(Name, Address and Telephone Number of Person Authorized to Receive
Notices and Communications)
Copy to:
Robert L. Lawrence, Esq.
Kane Kessler PC
1350 Avenue of the Americas
New York, New York 10019
(212) 541-6222
March 12, 2004
--------------------------------------------------------------------------------
(Date of Event which requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition which is the subject of this Schedule 13D, and is filing this
schedule because of ss.ss. 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the
following box / /.
SCHEDULE 13D
-------------------- -------------------------------
CUSIP NO. 255860108 Page 2 of 4 Pages
------- -----
-------------------- -------------------------------
--------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Jarden Corporation 35-1828377
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See
Instructions)
(a) [ ]
(b) [ ]
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
WC
--------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS 2(d) or 2(e) [ ]
--------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
DELAWARE
--------------------------------------------------------------------------------
7 SOLE VOTING POWER
0
NUMBER OF
SHARES ---------------------------------------------------------------
BENEFICIALLY 8 SHARED VOTING POWER
OWNED BY
EACH 440,000
REPORTING ---------------------------------------------------------------
PERSON 9 SOLE DISPOSITIVE POWER
WITH
0
---------------------------------------------------------------
10 SHARED DISPOSITIVE POWER
0
--------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
440,000
--------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
[ ]
--------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
13.74%
--------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
CO
--------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
This Amendment No. 3 to Schedule 13D ("Amendment No. 3") relates to
shares of the Common Stock, $1.00 par value per share (the "Shares"), of Dixon
Ticonderoga Company, a Delaware corporation (the "Issuer"). This Amendment No. 3
amends the initial statement (the "Schedule 13D") on Schedule 13D, dated January
9, 2004, of Jarden Corporation, a Delaware corporation, as amended by Amendment
No. 1 to Schedule 13D, dated February 11, 2004, and as further amended by
Amendment No. 2 to Schedule 13D, dated February 27, 2004. Capitalized terms used
in this Amendment No. 3 not otherwise defined have the meanings ascribed to them
in the Schedule 13D.
Information contained in this statement is as of the date hereof,
unless otherwise expressly provided herein.
Item 4. Purpose of the Transaction
Item 4 of the Schedule 13D is amended by adding the following paragraph
to the end of such item:
On March 12, 2004, the Reporting Person and the Issuer entered into a
Third Amendment to Exclusivity Agreement (the "Third Amendment to Exclusivity
Agreement") pursuant to which, among other things, the Reporting Person's
exclusive right to negotiate with the Issuer regarding a strategic transaction
was extended until April 12, 2004 (subject to earlier termination under certain
circumstances). A copy of the Third Amendment to Exclusivity Agreement is
annexed hereto as Exhibit 5, and the foregoing description of the Exclusivity
Agreement is qualified by the full text of the Exclusivity Agreement as amended
by the Amendment to Exclusivity Agreement, the Second Amendment to Exclusivity
Agreement and the Third Amendment to Exclusivity Agreement.
Item 7. Material to be Filed as Exhibits
Item 7 of the Schedule 13D is amended by adding the following Exhibit
No. 5 to the end of such item:
5. Third Amendment to Exclusivity Agreement, dated March 12,
2004, between Jarden Corporation and Dixon Ticonderoga
Company.
3
SIGNATURE
After reasonable inquiry and to the best of its knowledge and belief,
the undersigned certifies that the information set forth in this statement is
true, complete and correct.
Date: March 12, 2004.
JARDEN CORPORATION
By: /s/ Desiree DeStefano
----------------------------
Name: Desiree DeStefano
Title: Senior Vice President